Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide
- 25 October 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (50) , 7700-7709
- https://doi.org/10.1038/sj.onc.1205881
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 46 references indexed in Scilit:
- Systemic IFN-β gene therapy results in long-term survival in mice with established colorectal liver metastasesJournal of Clinical Investigation, 2001
- Interferons α and β as Immune Regulators—A New LookPublished by Elsevier ,2001
- Regression of Infancy Hemangiomas with Recombinant IFN-α2bJournal of Interferon & Cytokine Research, 2001
- All-trans retinoic acid and interferon-α in the treatment of a patient with resistant metastatic osteosarcomaCancer, 2000
- How Does Interferon-Alpha Exert Its Antitumour Activity in Multiple Myeloma?Acta Oncologica, 2000
- Differences in Activity between α and β Type I Interferons Explored by Mutational AnalysisJournal of Biological Chemistry, 1998
- Interferons and the tumor cellBiotherapy, 1996
- Interferons in Precancer and Cancer Prevention: Where Are We?Journal of Interferon & Cytokine Research, 1996
- p53 mutations in human tumors with chimeric EWS/FLI/1 genesInternational Journal of Cancer, 1994
- Exacerbation of Psoriasis with MeclofenamateNew England Journal of Medicine, 1983